|
[1]
|
Singer, M., Deutschman, C.S., Seymour, C.W., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Zhang, W., Wang, W., Hou, W., et al. (2022) The Diagnostic Utility of IL-10, IL-17, and PCT in Patients with Sepsis Infection. Frontiers in Public Health, 10, Article 923457. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Lippi, G. (2019) Sepsis Bi-omarkers: Past, Present and Future. Clinical Chemistry and Laboratory Medicine, 57, 1281-1283. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Downes, K.J., Fitzgerald, J.C. and Weiss, S.L. (2020) Utility of Pro-calcitonin as a Biomarker for Sepsis in Children. Journal of Clinical Microbiology, 58, e01851-19. [Google Scholar] [CrossRef]
|
|
[5]
|
Vijayan, A.L., Vanimaya, Ravindran, S., et al. (2017) Procalcitonin: A Promising Diagnostic Marker for Sepsis and Antibiotic Therapy. Journal of Intensive Care, 5, Article No. 51. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Müller, B., Becker, K.L., Schächinger, H., et al. (2000) Calcitonin Precursors Are Reliable Markers of Sepsis in a Medical Intensive Care Unit. Critical Care Medicine, 28, 977-983. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Schuetz, P., Beishuizen, A., Broyles, M., et al. (2019) Procalcitonin (PCT)-Guided Antibiotic Stewardship: An International Experts Consensus on Optimized Clinical Use. Clinical Chemistry and Laboratory Medicine, 57, 1308-1318. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Fisher, J. and Linder, A. (2017) Heparin-Binding Protein: A Key Player in the Pathophysiology of Organ Dysfunction in Sepsis. Journal of Internal Medicine, 281, 562-574. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Kahn, F., Tverring, J., Mellhammar, L., et al. (2019) Heparin-Binding Protein as a Prognostic Biomarker of Sepsis and Disease Severity at the Emergency Department. Shock, 52, e135-e145. [Google Scholar] [CrossRef]
|
|
[10]
|
Zhou, Y., Liu, Z., Huang, J., et al. (2019) Usefulness of the Heparin-Binding Protein Level to Diagnose Sepsis and Septic Shock according to Sepsis-3 Compared with Procalcitonin and C Reactive Protein: A Prospective Cohort Study in China. BMJ Open, 9, e026527. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Tverring, J., Nielsen, N., Dankiewicz, J., et al. (2020) Repeated Measures of Heparin-Binding Protein (HBP) and Procalcitonin during Septic Shock: Biomarker Kinetics and Association with Cardiovascular Organ Dysfunction. Intensive Care Medicine Experimental, 8, Article No. 51. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Han, X., Dou, Q., Zhu, Y., et al. (2022) Heparin-Binding Pro-tein-Enhanced Quick SOFA Score Improves Mortality Prediction in Sepsis Patients. Frontiers in Medicine, 9, Article 926798. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Katsaros, K., Renieris, G., Safarika, A., et al. (2022) Hep-arin Binding Protein for the Early Diagnosis and Prognosis of Sepsis in the Emergency Department: The Prompt Multi-center Study. Shock, 57, 518-525. [Google Scholar] [CrossRef]
|
|
[14]
|
Song, J., Park, D.W., Moon, S., et al. (2019) Diagnostic and Prognostic Value of Interleukin-6, Pentraxin 3, and Procalcitonin Levels among Sepsis and Septic Shock Patients: A Prospective Controlled Study according to the Sepsis-3 Definitions. BMC Infectious Diseases, 19, Article No. 968. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Zhang, Y., Li, B. and Ning, B. (2022) Evaluating IL-6 and IL-10 as Rapid Diagnostic Tools for Gram-Negative Bacteria and as Disease Severity Predictors in Pediatric Sepsis Patients in the Intensive Care Unit. Frontiers in Immunology, 13, Article 1043968. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Hu, P., Chen, Y., Pang, J. and Chen, X.H. (2019) Association between IL-6 Polymorphisms and Sepsis. Innate Immunity, 25, 465-472. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Mcelvaney, O.J., Curley, G.F., Rose-John, S. and McElvaney, N.G. (2021) Interleukin-6: Obstacles to Targeting a Complex Cytokine in Critical Illness. The Lancet. Respiratory Medi-cine, 9, 643-654. [Google Scholar] [CrossRef]
|
|
[18]
|
Takahashi, W., Nakada, T.A., Yazaki, M. and Oda, S. (2016) Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunc-tion in Intensive Care Units. Shock, 46, 254-260. [Google Scholar] [CrossRef]
|
|
[19]
|
Shao, W.X., Yu, D.J., Zhang, W.Y. and Wang, X.J. (2018) Clinical Significance of Interleukin-6 in the Diagnosis of Sepsis and Discriminating Sepsis Induced by Gram-Negative Bacteria. The Pediatric Infectious Disease Journal, 37, 801-805. [Google Scholar] [CrossRef]
|
|
[20]
|
Yu, B., Chen, M., Zhang, Y., et al. (2022) Diagnostic and Prognostic Value of Interleukin-6 in Emergency Department Sepsis Patients. Infection and Drug Resistance, 15, 5557-5566. [Google Scholar] [CrossRef]
|
|
[21]
|
Ling, H., Chen, M., Dai, J., et al. (2023) Evaluation of qSOFA Combined with Inflammatory Mediators for Diagnosing Sepsis and Predicting Mortality among Emergency De-partment. Clinica Chimica Acta, 544, Article ID: 117352. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Wagner, C., Deppisch, R., Denefleh, B., et al. (2003) Expression Patterns of the Lipopolysaccharide Receptor CD14, and the FCγ? Receptors CD16 and CD64 on Polymorphonuclear Neutrophils: Data from Patients with Severe Bacterial Infections and Lipopolysaccharide-Exposed Cells. Shock, 19, 5-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Cong, S., Ma, T., Di, X., et al. (2021) Diagnostic Value of Neutrophil CD64, Procalcitonin, and Interleukin-6 in Sepsis: A Meta-Analysis. BMC Infectious Diseases, 21, Article No. 384. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Hashem, H.E., Abdel Halim, R.M., El Masry, S.A., et al. (2020) The Utility of Neutrophil CD64 and Presepsin as Diagnostic, Prognostic, and Monitoring Biomarkers in Neo-natal Sepsis. International Journal of Microbiology, 2020, Article ID: 8814892. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Pham, H.M., Nguyen, D.L.M., Duong, M.C., et al. (2023) Neutrophil CD64—A Prognostic Marker of Sepsis in Intensive Care Unit: A Prospective Cohort Study. Frontiers in Medicine, 10, Article 1251221. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Wu, J., Zhan, X., Wang, S., et al. (2023) The Value of Plasma Presepsin as a Diagnostic and Prognostic Biomarker for Sepsis in Southern China. Inflammation Research, 72, 1829-1837. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Ruan, L., Chen, G.Y., Liu, Z., et al. (2018) The Combination of Procalcitonin and C-Reactive Protein or Presepsin Alone Improves the Accuracy of Diagnosis of Neo-natal Sepsis: A Meta-Analysis and Systematic Review. Critical Care, 22, Article No. 316. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Yoon, S.H., Kim, E.H., Kim, H.Y. and Ahn, J.G. (2019) Presepsin as a Diagnostic Marker of Sepsis in Children and Adolescents: A Systemic Review and Meta-Analysis. BMC Infectious Diseases, 19, Article No. 760. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Fujii, E., Fujino, K. and Eguchi, Y. (2019) An Evaluation of Clin-ical Inflammatory and Coagulation Markers in Patients with Sepsis: A Pilot Study. Acute Medicine & Surgery, 6, 158-164. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Aliu-Bejta, A., Atelj, A., Kurshumliu, M., et al. (2020) Presepsin Values as Markers of Severity of Sepsis. International Journal of Infectious Diseases, 95, 1-7. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Lee, S., Song, J., Park, D.W., et al. (2022) Diagnostic and Prognos-tic Value of Presepsin and Procalcitonin in Non-Infectious Organ Failure, Sepsis, and Septic Shock: A Prospective Ob-servational Study according to the Sepsis-3 Definitions. BMC Infectious Diseases, 22, Article No. 8. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Ruangsomboon, O., Panjaikaew, P., Monsomboon, A., et al. (2020) Diagnostic and Prognostic Utility of Presepsin for Sepsis in Very Elderly Patients in the Emergency Department. Clinica Chimica Acta, 510, 723-732. [Google Scholar] [CrossRef] [PubMed]
|